Drug delivery and toxicity of adjuvant chemotherapy for non-small cell lung cancer (NSCLC): Washington University experience.
Velcheti
Vamsidhar
V
Viswanathan
Avinash K
AK
Baggstrom
Maria Q
MQ
Govindan
Ramaswamy
R
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects*; D005260:Female; D006785:Hospitals, University; D006801:Humans; D008297:Male; D008485:Medical Audit; D008875:Middle Aged; D008923:Missouri; D012189:Retrospective Studies; D012577:Schools, Medical; D013534:Survival; D016896:Treatment Outcome
D000970:Antineoplastic Agents